Stay updated with breaking news from Affinity Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
15.05.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three months ended March ...
Medpace (NASDAQ:MEDP – Get Rating) and bioAffinity Technologies (NASDAQ:BIAF – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability. Institutional and Insider Ownership 82.5% of Medpace shares are owned by […]
BioAffinity Technologies, Inc. (NASDAQ:BIAF – Get Rating)’s stock price was down 1% during mid-day trading on Tuesday . The company traded as low as $2.02 and last traded at $2.03. Approximately 8,182 shares traded hands during trading, a decline of 99% from the average daily volume of 983,699 shares. The stock had previously closed at […]
A company's external contributors, like content creators, gig workers, and even app developers, will be considered part of the workforce, according to researchers.
BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, today announced that Michael Dougherty has joined... | May 1, 2023